0 XP   0   0   0

Recursion Pharmaceuticals Inc
Buy, Hold or Sell?

I guess you are interested in Recursion Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Recursion

Let's start. I'm going to help you getting a better view of Recursion Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Recursion Pharmaceuticals Inc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Recursion Pharmaceuticals Inc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Recursion Pharmaceuticals Inc. The closing price on 2022-09-30 was $10.64 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Recursion Pharmaceuticals Inc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Recursion Pharmaceuticals Inc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Recursion earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Recursion to the Biotechnology industry mean.
  • A Net Profit Margin of -309.0% means that $-3.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Recursion Pharmaceuticals Inc:

  • The MRQ is -854.3%. The company is making a huge loss. -2
  • The TTM is -309.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-854.3%TTM-309.0%-545.3%
TTM-309.0%YOY-1,547.0%+1,238.0%
TTM-309.0%5Y-4,831.5%+4,522.5%
5Y-4,831.5%10Y-4,831.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-854.3%-242.4%-611.9%
TTM-309.0%-275.9%-33.1%
YOY-1,547.0%-342.1%-1,204.9%
5Y-4,831.5%-475.7%-4,355.8%
10Y-4,831.5%-561.7%-4,269.8%
1.1.2. Return on Assets

Shows how efficient Recursion is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Recursion to the Biotechnology industry mean.
  • -8.8% Return on Assets means that Recursion generated $-0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Recursion Pharmaceuticals Inc:

  • The MRQ is -9.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.7%TTM-8.8%-0.9%
TTM-8.8%YOY-6.5%-2.3%
TTM-8.8%5Y-6.1%-2.7%
5Y-6.1%10Y-6.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.7%-9.7%0.0%
TTM-8.8%-8.7%-0.1%
YOY-6.5%-9.2%+2.7%
5Y-6.1%-11.5%+5.4%
10Y-6.1%-12.4%+6.3%
1.1.3. Return on Equity

Shows how efficient Recursion is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Recursion to the Biotechnology industry mean.
  • -15.0% Return on Equity means the company generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Recursion Pharmaceuticals Inc:

  • The MRQ is -15.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.0%TTM-11.6%-3.4%
TTM-11.6%YOY-1.7%-9.9%
TTM-11.6%5Y-5.3%-6.3%
5Y-5.3%10Y-5.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.0%-11.8%-3.2%
TTM-11.6%-11.1%-0.5%
YOY-1.7%-10.6%+8.9%
5Y-5.3%-13.5%+8.2%
10Y-5.3%-14.5%+9.2%

1.2. Operating Efficiency of Recursion Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Recursion is operating .

  • Measures how much profit Recursion makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Recursion to the Biotechnology industry mean.
  • An Operating Margin of -854.3% means the company generated $-8.54  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Recursion Pharmaceuticals Inc:

  • The MRQ is -854.3%. The company is operating very inefficient. -2
  • The TTM is -306.8%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-854.3%TTM-306.8%-547.6%
TTM-306.8%YOY-1,270.9%+964.2%
TTM-306.8%5Y-4,666.4%+4,359.6%
5Y-4,666.4%10Y-4,666.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-854.3%-232.1%-622.2%
TTM-306.8%-269.6%-37.2%
YOY-1,270.9%-309.3%-961.6%
5Y-4,666.4%-466.7%-4,199.7%
10Y-4,666.4%-572.5%-4,093.9%
1.2.2. Operating Ratio

Measures how efficient Recursion is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 962.5% means that the operating costs are $9.63for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Recursion Pharmaceuticals Inc:

  • The MRQ is 9.625. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.508. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ9.625TTM3.508+6.117
TTM3.508YOY15.847-12.338
TTM3.5085Y48.308-44.799
5Y48.30810Y48.3080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.6253.321+6.304
TTM3.5083.542-0.034
YOY15.8473.491+12.356
5Y48.3085.744+42.564
10Y48.3087.007+41.301

1.3. Liquidity of Recursion Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Recursion is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 564.9% means the company has $5.65 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Recursion Pharmaceuticals Inc:

  • The MRQ is 5.649. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.582. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.649TTM9.582-3.933
TTM9.582YOY10.463-0.880
TTM9.5825Y8.018+1.564
5Y8.01810Y8.0180.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.6495.266+0.383
TTM9.5826.060+3.522
YOY10.4636.366+4.097
5Y8.0186.692+1.326
10Y8.0186.457+1.561
1.3.2. Quick Ratio

Measures if Recursion is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Biotechnology industry mean)
  • A Quick Ratio of 609.1% means the company can pay off $6.09 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Recursion Pharmaceuticals Inc:

  • The MRQ is 6.091. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 12.035. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ6.091TTM12.035-5.945
TTM12.035YOY7.351+4.685
TTM12.0355Y7.754+4.281
5Y7.75410Y7.7540.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.0914.055+2.036
TTM12.0354.865+7.170
YOY7.3515.192+2.159
5Y7.7545.275+2.479
10Y7.7544.997+2.757

1.4. Solvency of Recursion Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Recursion assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Asset Ratio of 0.35 means that Recursion assets are financed with 34.9% credit (debt) and the remaining percentage (100% - 34.9%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Recursion Pharmaceuticals Inc:

  • The MRQ is 0.349. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.220. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.349TTM0.220+0.130
TTM0.220YOY0.907-0.687
TTM0.2205Y0.451-0.231
5Y0.45110Y0.4510.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3490.271+0.078
TTM0.2200.269-0.049
YOY0.9070.296+0.611
5Y0.4510.361+0.090
10Y0.4510.399+0.052
1.4.2. Debt to Equity Ratio

Measures if Recursion is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Biotechnology industry mean).
  • A Debt to Equity ratio of 53.7% means that company has $0.54 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Recursion Pharmaceuticals Inc:

  • The MRQ is 0.537. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.312. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.537TTM0.312+0.225
TTM0.312YOY0.022+0.290
TTM0.3125Y0.134+0.179
5Y0.13410Y0.1340.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5370.310+0.227
TTM0.3120.311+0.001
YOY0.0220.310-0.288
5Y0.1340.382-0.248
10Y0.1340.438-0.304

2. Market Valuation of Recursion Pharmaceuticals Inc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Recursion.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of -5.93 means the investor is paying $-5.93 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Recursion Pharmaceuticals Inc:

  • The EOD is -7.747. Company is losing money. -2
  • The MRQ is -5.927. Company is losing money. -2
  • The TTM is -13.757. Company is losing money. -2
Trends
Current periodCompared to+/- 
EOD-7.747MRQ-5.927-1.820
MRQ-5.927TTM-13.757+7.831
TTM-13.757YOY-12.622-1.136
TTM-13.7575Y-10.552-3.206
5Y-10.55210Y-10.5520.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.747-2.115-5.632
MRQ-5.927-2.332-3.595
TTM-13.757-3.889-9.868
YOY-12.622-5.087-7.535
5Y-10.552-3.697-6.855
10Y-10.552-3.390-7.162
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Recursion.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Recursion Pharmaceuticals Inc:

  • The MRQ is -0.066. Very Bad. -2
  • The TTM is -0.078. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-0.066TTM-0.078+0.012
TTM-0.0785Y-0.0780.000
5Y-0.07810Y-0.0780.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.0660.003-0.069
TTM-0.0780.019-0.097
5Y-0.0780.020-0.098
10Y-0.0780.017-0.095

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Recursion is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.20 means the investor is paying $3.20 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Recursion Pharmaceuticals Inc:

  • The EOD is 4.187. Neutral. Compare to industry.
  • The MRQ is 3.204. Neutral. Compare to industry.
  • The TTM is 4.374. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD4.187MRQ3.204+0.984
MRQ3.204TTM4.374-1.171
TTM4.374YOY1.964+2.410
TTM4.3745Y2.535+1.839
5Y2.53510Y2.5350.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.1871.843+2.344
MRQ3.2041.961+1.243
TTM4.3742.789+1.585
YOY1.9643.538-1.574
5Y2.5352.782-0.247
10Y2.5352.419+0.116

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Recursion Pharmaceuticals Inc.

3.1. Institutions holding Recursion Pharmaceuticals Inc

Institutions are holding 81.65% of the shares of Recursion Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-03-31Baillie Gifford & Co Limited.12.70050.110321981604-141551-0.6398
2022-03-31Vanguard Group Inc3.81990.001166113774975048.1373
2022-06-30Obvious Management Services, L.L.C.3.4537100597763100
2022-03-31LAURION CAPITAL MANAGEMENT LP2.65040.4018458727466356116.9116
2022-03-31AllianceBernstein L.P.1.95330.0093338071850489917.5567
2022-03-31ARK Investment Management LLC1.63350.0845282716359515026.6643
2022-03-31FMR Inc1.23970.0012214563961541340.2171
2022-03-31Junked Platinum Investment Management Ltd1.23450.4696213660469274147.9783
2022-06-30MV Management XI, L.L.C.1.139314.5859197190800
2022-03-31State Street Corporation1.10860.00071918734-2737993-58.7965
2022-03-31Credit Suisse First Boston (CSFB)0.9040.0096156460249840.3196
2022-06-30Harvard Management Co Inc0.8721.4223150925400
2022-03-31MIC Capital Management UK LLP0.80251.935138888900
2022-03-31Massachusetts Financial Services Company0.77230.00281336750367092.8237
2022-03-31Geode Capital Management, LLC0.74750.00121293756-1201-0.0927
2022-06-30Botty Investors LLC0.73234.0882126743000
2022-06-30Comprehensive Financial Management LLC0.6410.2532110939500
2022-03-31Citadel Advisors Llc0.52580.0013909970710363355.8808
2022-03-31Northern Trust Corp0.49660.0011859544-26417-2.9817
2022-03-31T. Rowe Price Associates, Inc.0.32480.0004562190-295383-34.4441
Total 37.7522123.379565340432  

3.2. Funds holding Recursion Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2022-05-31Scottish Mortgage Ord8.07010.47151396749600
2022-07-31ARK Genomic Revolution ETF1.98761.0455344007434840.1014
2022-07-31Baillie Gifford US Equity Growth1.8270.3966316209300
2022-06-30Vanguard US Growth Investor1.8270.0799316209300
2022-07-29iShares Russell 2000 ETF1.6810.0459290943125400.0874
2022-06-30ARK Genomic Revolution1.53680.91812659761-145575-5.1892
2022-07-31Vanguard Total Stock Mkt Idx Inv1.39360.0017241202100
2022-07-31Vanguard Small Cap Index1.19960.01452076186195670.9514
2022-06-30AB Small Cap Growth A1.14540.40561982478476302.4617
2022-06-30Baillie Gifford American B Inc1.12020.4555193880618880.0975
2022-06-30CS (Lux) Digital Health Equity SB USD0.86670.4902150000000
2022-07-31Vanguard Small Cap Growth Index Inv0.70440.03511219099-11942-0.9701
2022-07-29iShares Russell 2000 Value ETF0.70230.0835121547100
2022-06-30Fidelity Growth Compy Commingled Pl 30.63870.0187110551727808533.6082
2022-06-30MFS New Discovery I0.53140.339691967700
2022-05-31Fidelity® Small Cap Index0.52220.029490385500
2022-06-30Fidelity® Growth Company0.46950.016181257519838832.3009
2022-07-31State St Russell Sm/Mid Cp® Indx NL Cl C0.39750.017568803019000.2769
2022-07-29iShares Biotechnology ETF0.37540.0686649779-1006-0.1546
2022-06-30Baillie Gifford Managed B Acc0.34330.0633594090-4140-0.692
Total 27.33974.996847318532  

3.3. Insider Transactions

Insiders are holding 7.787% of the shares of Recursion Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2022-08-16Tina Marriott LarsonSELL1600012.6295107
2022-08-16Shafique ViraniSELL3000012.6198773
2022-08-04Christopher GibsonSELL368259.49541829
2022-07-07Christopher GibsonSELL371149.05528904
2022-06-02Christopher GibsonSELL396906.09516268
2022-05-04Christopher GibsonSELL318306.49511972
2022-04-28Christopher GibsonSELL376056.09469608
2022-04-21Christopher GibsonSELL371556.31420146
2022-04-18Christopher GibsonSELL358366.84394791
2022-04-14Christopher GibsonSELL345177.56368117
2022-04-07Christopher GibsonSELL367186.54314534
2022-04-05Christopher GibsonSELL344727.43288742
2022-03-14Christopher GibsonSELL2300006.28
2022-03-11Christopher GibsonSELL1000006.95
2022-03-07Christopher GibsonSELL3000007.3
2022-02-22Christopher GibsonSELL10000010.22
2022-01-31Christopher GibsonSELL1985811.73
2022-01-13Christopher GibsonSELL8700014.33
2022-01-04Blake BorgesonSELL962518.03
2021-12-21Blake BorgesonSELL962518.75

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Recursion Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--2.5413.048-17%0.457+456%1.402+81%1.402+81%
Book Value Per Share Growth---0.351-0.526+50%1.161-130%0.254-238%0.254-238%
Current Ratio--5.6499.582-41%10.463-46%8.018-30%8.018-30%
Debt To Asset Ratio--0.3490.220+59%0.907-61%0.451-22%0.451-22%
Debt To Equity Ratio--0.5370.312+72%0.022+2370%0.134+302%0.134+302%
Dividend Per Share----0%-0%-0%-0%
Eps---0.381-0.343-10%-0.181-53%-0.243-36%-0.243-36%
Eps Growth--89.975110.663-19%--110.663-19%110.663-19%
Gains Per Share---0.351-0.526+50%1.161-130%0.254-238%0.254-238%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin---8.543-3.090-64%-15.470+81%-48.315+466%-48.315+466%
Operating Margin---8.543-3.068-64%-12.709+49%-46.664+446%-46.664+446%
Operating Ratio--9.6253.508+174%15.847-39%48.308-80%48.308-80%
Pb Ratio4.187+23%3.2044.374-27%1.964+63%2.535+26%2.535+26%
Pe Ratio-7.747-31%-5.927-13.757+132%-12.622+113%-10.552+78%-10.552+78%
Peg Ratio---0.066-0.078+19%---0.078+19%-0.078+19%
Price Per Share10.640+23%8.14013.860-41%9.125-11%9.194-11%9.194-11%
Quick Ratio--6.09112.035-49%7.351-17%7.754-21%7.754-21%
Return On Assets---0.097-0.088-10%-0.065-33%-0.061-37%-0.061-37%
Return On Equity---0.150-0.116-23%-0.017-89%-0.053-65%-0.053-65%
 EOD+1 -2MRQTTM+4 -14YOY+6 -105Y+6 -1210Y+6 -12

4.2. Fundamental Score

Let's check the fundamental score of Recursion Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.747
Price to Book Ratio (EOD)Between0-14.187
Net Profit Margin (MRQ)Greater than0-8.543
Operating Margin (MRQ)Greater than0-8.543
Quick Ratio (MRQ)Greater than16.091
Current Ratio (MRQ)Greater than15.649
Debt to Asset Ratio (MRQ)Less than10.349
Debt to Equity Ratio (MRQ)Less than10.537
Return on Equity (MRQ)Greater than0.15-0.150
Return on Assets (MRQ)Greater than0.05-0.097
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Recursion Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.175
Ma 20Greater thanMa 5011.563
Ma 50Greater thanMa 10010.571
Ma 100Greater thanMa 2008.897
OpenGreater thanClose10.700
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets672,515
Total Liabilities234,936
Total Stockholder Equity437,579
 As reported
Total Liabilities 234,936
Total Stockholder Equity+ 437,579
Total Assets = 672,515

Assets

Total Assets672,515
Total Current Assets545,996
Long-term Assets545,996
Total Current Assets
Cash And Cash Equivalents 453,875
Short-term Investments 61,561
Net Receivables 11,680
Other Current Assets 18,880
Total Current Assets  (as reported)545,996
Total Current Assets  (calculated)545,996
+/-0
Long-term Assets
Property Plant Equipment 116,151
Goodwill 801
Intangible Assets 1,233
Other Assets 8,334
Long-term Assets  (as reported)126,519
Long-term Assets  (calculated)126,519
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities96,653
Long-term Liabilities138,283
Total Stockholder Equity437,579
Total Current Liabilities
Short-term Debt 5,335
Short Long Term Debt 93
Accounts payable 3,176
Other Current Liabilities 24,361
Total Current Liabilities  (as reported)96,653
Total Current Liabilities  (calculated)32,965
+/- 63,688
Long-term Liabilities
Long term Debt Total 586
Capital Lease Obligations Min Short Term Debt47,670
Other Liabilities 89,934
Long-term Liabilities  (as reported)138,283
Long-term Liabilities  (calculated)138,190
+/- 93
Total Stockholder Equity
Common Stock2
Retained Earnings -521,619
Accumulated Other Comprehensive Income -197
Capital Surplus 959,393
Total Stockholder Equity (as reported)437,579
Total Stockholder Equity (calculated)437,579
+/-0
Other
Capital Stock2
Cash and Short Term Investments 515,436
Common Stock Shares Outstanding 172,212
Common Stock Total Equity2
Current Deferred Revenue63,781
Liabilities and Stockholders Equity 672,515
Net Debt -400,191
Net Invested Capital 438,258
Net Tangible Assets 435,545
Net Working Capital 449,343
Short Long Term Debt Total 53,684



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-31
> Total Assets 
0
0
0
298,585
271,943
698,590
658,606
610,345
734,319
672,515
672,515734,319610,345658,606698,590271,943298,585000
   > Total Current Assets 
0
0
0
269,478
221,822
647,635
600,870
534,718
619,455
545,996
545,996619,455534,718600,870647,635221,822269,478000
       Cash And Cash Equivalents 
0
0
0
262,126
214,088
632,738
394,721
285,116
507,891
453,875
453,875507,891285,116394,721632,738214,088262,126000
       Short-term Investments 
0
0
0
0
0
0
184,189
231,446
83,214
61,561
61,56183,214231,446184,189000000
       Net Receivables 
0
0
0
156
71
49
2,282
9,090
11,397
11,680
11,68011,3979,0902,2824971156000
       Other Current Assets 
0
0
0
2,155
7,663
14,848
19,678
9,066
16,953
18,880
18,88016,9539,06619,67814,8487,6632,155000
   > Long-term Assets 
0
0
0
29,107
50,121
50,955
57,736
75,627
114,864
126,519
126,519114,86475,62757,73650,95550,12129,107000
       Property Plant Equipment 
0
0
0
0
44,642
48,549
55,439
64,725
104,005
116,151
116,151104,00564,72555,43948,54944,6420000
       Goodwill 
0
0
0
0
0
0
801
801
801
801
801801801801000000
       Intangible Assets 
0
0
0
2,490
2,414
2,338
1,461
1,385
1,309
1,233
1,2331,3091,3851,4612,3382,4142,490000
       Other Assets 
0
0
0
0
3,065
68
35
8,716
8,749
8,334
8,3348,7498,71635683,0650000
> Total Liabilities 
0
0
0
504,874
504,974
55,876
59,574
67,407
240,753
234,936
234,936240,75367,40759,57455,876504,974504,874000
   > Total Current Liabilities 
0
0
0
23,099
26,854
29,540
42,943
46,658
85,705
96,653
96,65385,70546,65842,94329,54026,85423,099000
       Short-term Debt 
0
0
0
0
2,644
3,634
1,504
90
4,178
5,335
5,3354,178901,5043,6342,6440000
       Short Long Term Debt 
0
0
0
1,073
2,145
3,135
88
90
92
93
939290883,1352,1451,073000
       Accounts payable 
0
0
0
1,074
3,125
3,196
6,326
2,819
4,162
3,176
3,1764,1622,8196,3263,1963,1251,074000
       Other Current Liabilities 
0
0
0
0
11,085
12,710
25,113
33,749
23,118
24,361
24,36123,11833,74925,11312,71011,0850000
   > Long-term Liabilities 
0
0
0
481,775
478,120
26,336
16,631
20,749
155,048
138,283
138,283155,04820,74916,63126,336478,120481,775000
       Long term Debt Total 
0
0
0
0
0
0
656
633
610
586
586610633656000000
       Warrants
0
0
0
0
448,312
0
0
0
0
0
00000448,3120000
       Other Liabilities 
0
0
0
0
16,917
14,486
12,515
20,116
107,121
89,934
89,934107,12120,11612,51514,48616,9170000
       Deferred Long Term Liability 
0
0
0
0
2,750
2,819
3,348
4,110
0
0
004,1103,3482,8192,7500000
> Total Stockholder Equity
0
0
0
-206,289
-233,031
642,714
599,032
542,938
493,566
437,579
437,579493,566542,938599,032642,714-233,031-206,289000
   Common Stock
0
0
0
0
0
2
2
2
2
2
2222200000
   Retained Earnings Total Equity-521,619-456,059-400,080-335,147-287,719-244,3180000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
2
-126
-309
-197
-197-309-1262000000
   Capital Surplus 
0
0
0
0
11,287
930,431
934,175
943,142
949,932
959,393
959,393949,932943,142934,175930,43111,2870000
   Treasury Stock0000000000
   Other Stockholders Equity 
0
0
0
0
0
930,431
934,175
943,142
949,932
959,393
959,393949,932943,142934,175930,43100000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue10,178
Cost of Revenue--
Gross Profit10,17810,178
 
Operating Income (+$)
Gross Profit10,178
Operating Expense-192,953
Operating Income-182,775-182,775
 
Operating Expense (+$)
Research Development135,271
Selling General Administrative57,682
Selling And Marketing Expenses-
Operating Expense192,953192,953
 
Net Interest Income (+$)
Interest Income73
Interest Expense-2,952
Net Interest Income-2,879-2,879
 
Pretax Income (+$)
Operating Income-182,775
Net Interest Income-2,879
Other Non-Operating Income Expenses-3,704
Income Before Tax (EBT)-186,479-179,071
EBIT - interestExpense = -189,431
-186,479
-183,527
Interest Expense2,952
Earnings Before Interest and Taxes (ebit)-186,479-183,527
Earnings Before Interest and Taxes (ebitda)-178,074
 
After tax Income (+$)
Income Before Tax-186,479
Tax Provision--
Net Income From Continuing Ops-186,479-186,479
Net Income-186,479
Net Income Applicable To Common Shares-186,479
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-3,7046,583
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
VOLT.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of VOLT.CC.

VOLT.CC Daily Candlestick Chart
VOLLAR.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of VOLLAR.CC.

VOLLAR.CC Daily Candlestick Chart
VIB.CC
6 hours ago

I found you a RSI Bullish Hidden Divergence on the daily chart of VIB.CC.

VIB.CC Daily Candlestick Chart
TRIO.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of TRIO.CC.

TRIO.CC Daily Candlestick Chart
TKX.CC
6 hours ago

I found you a Golden Cross on the daily chart of TKX.CC.

TKX.CC Daily Candlestick Chart
TERC.CC
6 hours ago

I found you a Three Black Crows Candle Pattern on the daily chart of TERC.CC.

TERC.CC Daily Candlestick Chart
RENTBERRY.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of RENTBERRY.CC.

RENTBERRY.CC Daily Candlestick Chart
STOX.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of STOX.CC.

STOX.CC Daily Candlestick Chart
STO.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of STO.CC.

STO.CC Daily Candlestick Chart
STM.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of STM.CC.

STM.CC Daily Candlestick Chart
SPORTS.CC
6 hours ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SPORTS.CC.

SPORTS.CC Daily Candlestick Chart
SPIRIT.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of SPIRIT.CC.

SPIRIT.CC Daily Candlestick Chart
SHIELD.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHIELD.CC.

SHIELD.CC Daily Candlestick Chart
SHB.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SHB.CC.

SHB.CC Daily Candlestick Chart
SFM.CC
6 hours ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of SFM.CC.

SFM.CC Daily Candlestick Chart
QI.CC
6 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of QI.CC.

QI.CC Daily Candlestick Chart
PYRO.CC
6 hours ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of PYRO.CC.

PYRO.CC Daily Candlestick Chart
PTF.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PTF.CC.

PTF.CC Daily Candlestick Chart
PREMIA.CC
6 hours ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of PREMIA.CC.

PREMIA.CC Daily Candlestick Chart
POX.CC
6 hours ago

I found you a Death Cross on the daily chart of POX.CC.

POX.CC Daily Candlestick Chart
PLURA.CC
6 hours ago

I found you a MACD Bearish Reversal Divergence on the daily chart of PLURA.CC.

PLURA.CC Daily Candlestick Chart
PLAY.CC
6 hours ago

I found you a MACD Bullish Hidden Divergence on the daily chart of PLAY.CC.

PLAY.CC Daily Candlestick Chart
PHR.CC
6 hours ago

I found you a Bearish Three Line Strike Candle Pattern on the daily chart of PHR.CC.

PHR.CC Daily Candlestick Chart
PAYT.CC
6 hours ago

I found you a MACD Bearish Hidden Divergence on the daily chart of PAYT.CC.

PAYT.CC Daily Candlestick Chart